Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Janet Rader to Neoplasm Proteins

This is a "connection" page, showing publications Janet Rader has written about Neoplasm Proteins.

 
Connection Strength
 
 
 
0.682
 
  1. Grigsby PW, Watson M, Powell MA, Zhang Z, Rader JS. Gene expression patterns in advanced human cervical cancer. Int J Gynecol Cancer. 2006 Mar-Apr; 16(2):562-7.
    View in: PubMed
    Score: 0.225
  2. Rader JS, Pan A, Corbin B, Iden M, Lu Y, Vellano CP, Akbani R, Mills GB, Simpson P. Identification and validation of a prognostic proteomic signature for cervical cancer. Gynecol Oncol. 2019 11; 155(2):324-330.
    View in: PubMed
    Score: 0.144
  3. Liapis H, Crouch EC, Roby J, Rader JS. In situ localization of parathyroid hormone-like protein and mRNA in intraepithelial neoplasia and invasive carcinoma of the uterine cervix. Hum Pathol. 1993 Oct; 24(10):1058-66.
    View in: PubMed
    Score: 0.095
  4. Horowitz N, Pinto K, Mutch DG, Herzog TJ, Rader JS, Gibb R, Bocker-Edmonston T, Goodfellow PJ. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia. Gynecol Oncol. 2002 Jul; 86(1):62-8.
    View in: PubMed
    Score: 0.044
  5. Whelan AJ, Babb S, Mutch DG, Rader J, Herzog TJ, Todd C, Ivanovich JL, Goodfellow PJ. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers. Int J Cancer. 2002 Jun 10; 99(5):697-704.
    View in: PubMed
    Score: 0.043
  6. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene. 2001 Mar 22; 20(12):1509-18.
    View in: PubMed
    Score: 0.040
  7. Cohn D, Mutch D, Elbendary A, Rader J, Herzog T, Goodfellow P. No evidence for BCL10 mutation in endometrial cancers with microsatellite instability. Hum Mutat. 2001 Feb; 17(2):117-21.
    View in: PubMed
    Score: 0.040
  8. Kowalski LD, Mutch DG, Herzog TJ, Rader JS, Goodfellow PJ. Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. Genes Chromosomes Cancer. 1997 Mar; 18(3):219-27.
    View in: PubMed
    Score: 0.030
  9. Buttin BM, Powell MA, Mutch DG, Babb SA, Huettner PC, Edmonston TB, Herzog TJ, Rader JS, Gibb RK, Whelan AJ, Goodfellow PJ. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet. 2004 Jun; 74(6):1262-9.
    View in: PubMed
    Score: 0.012
  10. Fullwood P, Marchini S, Rader JS, Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER, Latif F. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res. 1999 Sep 15; 59(18):4662-7.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.